Showing results (3111-3120 of 31,410) with videos related to
Sort By:
Pageof 3,141
Journal of Medicinal Chemistry|October 3, 2003
S-acyl-2-thioethyl phosphoramidate diester derivatives as mononucleotide prodrugsDavid Egron, Jean-Louis Imbach, Gilles Gosselin, et al.Journal of Medicinal Chemistry|October 3, 2003
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimeticsPeter S Dragovich, Thomas J Prins, Ru Zhou, et al.Journal of Medicinal Chemistry|October 3, 2003
Probing the interactions of phosphosulfomannans with angiogenic growth factors by surface plasmon resonanceSiska Cochran, Caiping Li, Jon K Fairweather, et al.Journal of Medicinal Chemistry|November 13, 1992
Design and synthesis of novel FKBP inhibitorsJ R Hauske, P Dorff, S Julin, et al.Journal of Medicinal Chemistry|November 13, 1992
Effect of conformational mobility and hydrogen-bonding interactions on the selectivity of some guanidinoaryl-substituted mechanism-based inhibitors of trypsin-like serine proteasesR Rai, J A KatzenellenbogenJournal of Medicinal Chemistry|November 13, 1992
Synthesis and biological evaluation of conformationally restricted 2-(1-pyrrolidinyl)-N-[2-(3,4-dichlorophenyl)ethyl]-N-methylethylenediam ines as sigma receptor ligands. 1. Pyrrolidine, piperidine, homopiperidine, and tetrahydroisoquinoline classesB R de Costa, C Dominguez, X S He, et al.Journal of Medicinal Chemistry|November 13, 1992
Synthesis and biological activity of 4-(diphenylmethyl)-alpha-[(4-quinolinyloxy)methyl]-1-piperazineethanol and related compoundsI Sircar, S J Haleen, S E Burke, et al.Journal of Medicinal Chemistry|November 13, 1992
Diamine ligand release from the cisplatin analogue [meso-1,2-bis(2,6-dichloro-4- hydroxyphenyl)ethylenediamine]dichloroplatinum(II) in cell culture mediumP J Bednarski, B Trümbach, N A Kratochwil, et al.Journal of Medicinal Chemistry|October 31, 2003
Nitroaryl phosphoramides as novel prodrugs for E. coli nitroreductase activation in enzyme prodrug therapyLongqin Hu, Chengzhi Yu, Yongying Jiang, et al.Journal of Medicinal Chemistry|May 15, 1992
Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 2. Tricyclic pyridobenzoxazepinones and dibenzoxazepinonesJ M Klunder, K D Hargrave, M West, et al.Pageof 3,141